Unicycive Therapeutics Inc. (NASDAQ: UNCY)
$0.49
N/A ( 0% ) 492.5K
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.
Market Data
Open
$0.49
Previous close
$0.49
Volume
492.5K
Market cap
$42.75M
Day range
$0.48 - $0.50
52 week range
$0.34 - $1.82
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Apr 17, 2024 |
4 | Insider transactions | 1 | Apr 17, 2024 |
4 | Insider transactions | 1 | Apr 17, 2024 |
4 | Insider transactions | 1 | Apr 17, 2024 |
pre | Proxies and info statements | 1 | Apr 16, 2024 |
8-k | 8K-related | 15 | Mar 29, 2024 |
10-k | Annual reports | 100 | Mar 28, 2024 |
8-k | 8K-related | 18 | Mar 14, 2024 |
8-k | 8K-related | 24 | Mar 14, 2024 |
8-k | 8K-related | 14 | Feb 21, 2024 |